NCAM1 and lymphoma: One possible solution would be to expand the panel of T-cell markers in FC with antibodies against CD26, CD279 (PD-1), CD10, CD30, CD56, and CD57, which would improve the detection of clonal T-cells and increase the diagnostic accuracy in various lymphomas.